Manufacturing Execution System (MES) software for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed

{
  "id": "010273-2024",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 1,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "2",
        "value": 1,
        "measure": "smeBids",
        "relatedLot": "1"
      }
    ]
  },
  "date": "2024-03-28T12:07:25Z",
  "ocid": "ocds-h6vhtk-044e2e",
  "buyer": {
    "id": "GB-FTS-25759",
    "name": "Catapult CT"
  },
  "awards": [
    {
      "id": "010273-2024-SEA0045-1",
      "title": "Manufacturing Execution System (MES) software for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-109390",
          "name": "Autolomous Ltd"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "SEA0045",
    "lots": [
      {
        "id": "1",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Provision of a  Manufacturing Execution System (MES) tailored explicitly for the field of cell therapies, The MES platform should enable resource scheduling, inventory optimisation, management & execution of electronic batch records and overall manufacturing workflows, review and release activities. All workflows should be client-configurable and controlled, through the use of a zero-code, platform-embedded, builder configuration tool. The  platform should be designed to comply with US FDA, EU EMA & UK MHRA guidance and aligns with the GAMP5 validation methodology, as well as being CFR 21 Part 11 compliant.",
        "awardCriteria": {
          "criteria": [
            {
              "type": "price"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "Stevenage"
        },
        "deliveryAddresses": [
          {
            "region": "UKH23"
          }
        ]
      }
    ],
    "title": "Manufacturing Execution System (MES) software for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "Provision of a  Manufacturing Execution System (MES) tailored explicitly for the field of cell therapies, The MES platform should enable resource scheduling, inventory optimisation, management & execution of electronic batch records and overall manufacturing workflows, review and release activities. All workflows should be client-configurable and controlled, through the use of a zero-code, platform-embedded, builder configuration tool. The  platform should be designed to comply with US FDA, EU EMA & UK MHRA guidance and aligns with the GAMP5 validation methodology, as well as being CFR 21 Part 11 compliant.",
    "classification": {
      "id": "72212323",
      "scheme": "CPV",
      "description": "Computer-aided manufacturing (CAM) software development services"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "services",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "The provision of services involved are purely for the purpose of research, experimentation, study or development, Autolomous have developed a Manufacturing Execution System tailored explicitly for the field of cell therapies. Unlike other MES solutions repurposed from different sectors, Autolomous? offering is designed from the ground up to meet the unique challenges and complexities inherent in cell therapy manufacturing processes. Autolomous? aim is to democratise access to life-altering treatments, making them universally available, economically viable, and logistically feasible.\nCentral to this software suite is the autoloMATE platform. The MES platform enables resource scheduling, inventory optimisation, management & execution of electronic batch records and overall manufacturing workflows, review and release activities. All workflows are client-configurable and controlled, through the use of a zero-code, platform-embedded, builder configuration tool. The autoloMATE platform has been designed to comply with US FDA, EU EMA & UK MHRA guidance and aligns with the GAMP5 validation methodology, as well as being CFR 21 Part 11 compliant.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_PROTECT_RIGHTS",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-FTS-25759",
      "name": "Catapult CT",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKH23",
        "locality": "Stevenage",
        "postalCode": "SG1 2FX",
        "countryName": "United Kingdom",
        "streetAddress": "Cell and Gene Therapy Manufacturing Centre, Gunnels Wood Road"
      },
      "details": {
        "url": "https://ct.catapult.org.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "id": "07964711",
        "legalName": "Catapult CT"
      },
      "contactPoint": {
        "email": "procurement@ct.catapult.org.uk"
      }
    },
    {
      "id": "GB-FTS-109390",
      "name": "Autolomous Ltd",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKI41",
        "locality": "London",
        "postalCode": "N1 7GU",
        "countryName": "United Kingdom",
        "streetAddress": "20-22 Wenlock Road"
      },
      "details": {
        "url": "https://autolomous.com/",
        "scale": "sme"
      },
      "identifier": {
        "id": "11810723",
        "legalName": "Autolomous Ltd"
      },
      "contactPoint": {
        "email": "info@autolomous.com"
      }
    },
    {
      "id": "GB-FTS-85840",
      "name": "Catapult CT",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Stevenage",
        "countryName": "United Kingdom"
      },
      "identifier": {
        "legalName": "Catapult CT"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "010273-2024-SEA0045-1",
      "title": "Manufacturing Execution System (MES) software for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed",
      "value": {
        "amount": 350000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "010273-2024-SEA0045-1",
      "dateSigned": "2024-03-26T00:00:00Z"
    }
  ],
  "initiationType": "tender"
}